<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26291071</article-id>
      <article-id pub-id-type="pmc">4550169</article-id>
      <article-id pub-id-type="publisher-id">15-0097</article-id>
      <article-id pub-id-type="doi">10.3201/eid2109.150097</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
        <subj-group subj-group-type="TOC-title">
          <subject><italic>Bifidobacterium breve</italic> Sepsis in Child with High-Risk Acute Lymphoblastic Leukemia</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Bifidobacterium breve</italic> Sepsis in Child with High-Risk Acute Lymphoblastic Leukemia</article-title>
        <alt-title alt-title-type="running-head"><italic>Bifidobacterium breve</italic> Sepsis in Child</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Avcin</surname>
            <given-names>Simona Lucija</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pokorn</surname>
            <given-names>Marko</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kitanovski</surname>
            <given-names>Lidija</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Premru</surname>
            <given-names>Manica Mueller</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jazbec</surname>
            <given-names>Janez</given-names>
          </name>
        </contrib>
        <aff id="aff1">University Medical Centre, Ljubljana, Slovenia (S.L. Avcin, M. Pokorn, L. Kitanovski, J. Jazbec); </aff>
        <aff id="aff2">Institute for Microbiology and Immunology, Ljubljana (M.M. Premru)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Simona Avcin, University Children&#x2019;s Hospital, University Medical Centre, Bohoriceva 20, Ljubljana, Slovenia; email: <email xlink:href="simona.avcin@kclj.si">simona.avcin@kclj.si</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <volume>21</volume>
      <issue>9</issue>
      <fpage>1674</fpage>
      <lpage>1675</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>
          <italic>Bifidobacterium breve</italic>
        </kwd>
        <kwd>sepsis</kwd>
        <kwd>leukemia</kwd>
        <kwd>bacteria</kwd>
        <kwd>probiotics</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Patients with cancer often consume probiotics as part of their diet, although therapeutic use of probiotics is not recommended because of their potential invasiveness. In a recent review, 5 cases of probiotic treatment&#x2013;related bacteremia were identified in oncology patients, although no cases of invasive <italic>Bifidobacterium</italic> spp. infection were included (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). We describe a case of <italic>B. breve</italic> sepsis in a child with Philadelphia chromosome&#x2013;positive acute B-cell lymphoblastic leukemia.</p>
    <p>The patient was a previously healthy 2-year-old boy who had no history of immunodeficiency and whose leukocyte counts had been within reference ranges during check-up visits before his diagnosis. After leukemia was diagnosed, chemotherapy was started (prednisone, vincristine, doxorubicin, and L-asparaginase). During the second week of treatment, the boy experienced abdominal discomfort and constipation. Two weeks later, his condition worsened; he refused food, his abdomen was distended, and he had colicky pain. Thickened intestinal wall and fecal masses were seen ultrasonographically. Twelve hours later he became hypotensive. Laboratory test results showed severe neutropenia and increased inflammatory markers (<xref ref-type="fig" rid="F1">Figure</xref>). Two aerobic and anaerobic blood culture samples were collected from a central venous line (implantable venous access system) in a 30-minute span, and treatment with piperacillin/tazobactam, vancomycin, and gentamicin was empirically initiated according to local recommendations for pediatric febrile neutropenia with shock. Both anaerobic blood cultures were positive. Gram-positive, irregular rods with bifid and branching forms without spores grew anaerobically on blood agar with hemin and vitamin K after 48 hours of incubation and were identified as <italic>B. breve</italic> by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Bruker Daltonics, Billerica, MA, USA). The bacteria were susceptible to penicillin (MIC 0.250 &#x3BC;g/mL), ampicillin, amoxicillin/clavulanic acid, piperacillin/tazobactam (MIC 0.125 &#x3BC;g/mL), imipenem, and clindamycin but not metronidazole. Gentamicin and vancomycin were discontinued, and piperacillin/tazobactam was replaced by penicillin (<xref ref-type="fig" rid="F1">Figure</xref>). The patient stayed afebrile, and his neutropenia resolved. A blood culture taken on the eighth day of antimicrobial drug treatment was negative, and the central venous line was not replaced at that time. Bowel movement normalized and was maintained. We reviewed the ingredients of the food that the child received and documented the presence of <italic>Lactobacillus</italic> spp. and <italic>B. longum</italic> but not <italic>B. breve</italic>.</p>
    <fig id="F1" fig-type="figure" position="float">
      <label>Figure</label>
      <caption>
        <p>Schematic presentation of leukocyte count, C-reactive protein, and procalcitonin serum levels in clinical course of <italic>Bifidobacterium breve</italic> sepsis. Arrows indicate the name and duration of each antimicrobial drug treatment.</p>
      </caption>
      <graphic xlink:href="15-0097-F"/>
    </fig>
    <p>Some probiotics are part of the normal intestinal microbiota and rarely cause invasive infections (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). Although <italic>Bifidobacterium</italic> spp. is infrequently associated with infections (&lt;5% of anaerobic isolates), it occasionally causes serious illness. On the rare occasions when it is isolated from patients with bloodstream infections, it is usually isolated along with other causative agents. The number of reported deaths associated with anaerobic nonsporulating gram-positive rods is low (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>). In this patient, abdominal symptoms coincided with 2 blood cultures that yielded <italic>B. breve</italic>. We assume bacteria translocated through the distended colonic wall during chemotherapy-induced neutropenia and believe that the blood culture isolate was not a contaminant because it was isolated from 2 samples taken in a 30-min span. It is the practice at our institution not to take peripheral blood cultures simultaneously because doing so does not increase diagnostic accuracy.</p>
    <p>We found 1 description in the literature of <italic>B. breve</italic> septicemia in a neonate with omphalocele who had received probiotic therapy (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). In a review of <italic>Bifidobacterium</italic> spp. isolates during 2000&#x2013;2007 in 2 US hospitals, <italic>B. breve</italic> was isolated from blood culture from 3 adult patients (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). Two of these infections were associated with ileal resection or peritonitis and 1 with decubitus ulcers. No data on antimicrobial drug treatment were available. <italic>Bifidobacterium</italic> spp. sepsis was reported in an infant of extremely low birthweight 10 days after probiotic supplementation who recovered after antimicrobial drug therapy, although stenosis of the colon developed 6 weeks later (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>). Blood culture grew <italic>B. longum</italic> and <italic>B. infantis</italic>, which were probiotic strains. Apart from 1 case of sepsis caused by <italic>B. longum</italic> associated with acupuncture in a 19-year-old healthy patient (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>), we did not find other reports of invasive <italic>Bifidobacterium</italic> spp. infections. </p>
    <p>Because neutropenic episodes, even with bowel involvement, are common during treatment for cancer (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>), no reason to promote therapeutic use of probiotics has been proven. Probiotics can cause substantial bacterial overgrowth when stimulating factors are present. In our opinion, avoiding fecal impaction is crucial for preventing colonic bacterial overgrowth and minimizes the chance that bacteria will translocate and cause invasive infection. Nutritional recommendations for a neutropenic diet for children are still debated. The problem is not probiotic therapy but rather fermented food products to which small amounts of probiotics are added. After we reviewed the literature, we did not find enough data to safely recommend the use of these products in children receiving chemotherapy (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>). Nevertheless, probiotic therapy is recommended for many immunocompromised patients, such as preterm infants and persons with chronic inflammatory bowel disease (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>). We believe that this case of <italic>B. breve</italic> sepsis in an oncology patient underscores the invasive potential of probiotics.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Avcin SL, Pokorn M, Kitanovski L, Premru MM, Jazbec J. <italic>Bifidobacterium breve</italic> sepsis in child with high-risk acute lymphoblastic leukemia [letter]. Emerg Infect Dis. 2015 Sep [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2109.150097">http://dx.doi.org/10.3201/eid2109.150097</ext-link></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Redman</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Phillips</surname>
<given-names>RS</given-names></string-name>. <article-title>The efficacy and safety of probiotics in people with cancer.</article-title>
<source>Ann Oncol</source>. <year>2014</year>;<volume>25</volume>:<fpage>1919</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1093/annonc/mdu106</pub-id><pub-id pub-id-type="pmid">24618152</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Bottacini</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ventura</surname>
<given-names>M</given-names></string-name>, <string-name><surname>van Sinderen</surname>
<given-names>D</given-names></string-name>, <etal/>
<article-title>Diversity, ecology and intestinal function of bifidobacteria.</article-title>
<source>Microb Cell Fact</source>. <year>2014</year>;<volume>13(</volume><issue>Suppl 1</issue>:<fpage>S4</fpage>. <pub-id pub-id-type="doi">10.1186/1475-2859-13-S1-S4</pub-id><pub-id pub-id-type="pmid">25186128</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>de Vrese</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schrezenmeir</surname>
<given-names>J</given-names></string-name>. <article-title>Probiotics, prebiotics, and synbiotics.</article-title>
<source>Adv Biochem Eng Biotechnol</source>. <year>2008</year>;<volume>111</volume>:<fpage>1</fpage>&#x2013;<lpage>66. http://dx.doi.org/</lpage>.<pub-id pub-id-type="doi">10.1007/10_2008_097</pub-id><pub-id pub-id-type="pmid">18461293</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Ohishi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Takahashi</surname>
<given-names>S</given-names></string-name>, Ito Y, <string-name><surname>Ohishi</surname>
<given-names>Y</given-names></string-name>, Tsukamoto K, Nanba Y, <etal/>
<article-title><italic>Bifidobacterium</italic> septicemia associated with postoperative probiotic therapy in a neonate with omphalocele.</article-title>
<source>J Pediatr</source>. <year>2010</year>;<volume>156</volume>:<fpage>679</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2009.11.041</pub-id><pub-id pub-id-type="pmid">20303445</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Mahlen</surname>
<given-names>SD</given-names></string-name>. <article-title>Clarridge JE 3rd. Site and clinical significance of <italic>Alloscardovia omnicolens</italic> and <italic>Bifidobacterium</italic> species isolated in the clinical laboratory.</article-title>
<source>J Clin Microbiol</source>. <year>2009</year>;<volume>47</volume>:<fpage>3289</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00555-09</pub-id><pub-id pub-id-type="pmid">19641056</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Jenke</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ruf</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Hoppe</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Heldmann</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wirth</surname>
<given-names>S</given-names></string-name>. <article-title>Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source>. <year>2012</year>;<volume>97</volume>:<fpage>F217</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2011-300838</pub-id><pub-id pub-id-type="pmid">22058179</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Ha</surname>
<given-names>GY</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>H</given-names></string-name>, <etal/>
<article-title>Case of sepsis caused by <italic>Bifidobacterium longum</italic>.</article-title>
<source>J Clin Microbiol</source>. <year>1999</year>;<volume>37</volume>:<fpage>1227</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">10074561</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Rizzatti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Brandalise</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>de Azevedo</surname>
<given-names>AC</given-names></string-name>, Pinheiro VR, Aguir Sdos S<etal/>
<article-title>Neutropenic enterocolitis in children and young adults with cancer: prognostic value of clinical and image findings.</article-title>
<source>Pediatr Hematol Oncol</source>. <year>2010</year>;<volume>27</volume>:<fpage>462</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.3109/08880018.2010.489934</pub-id><pub-id pub-id-type="pmid">20578807</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Moody</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Charlson</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Finlay</surname>
<given-names>J</given-names></string-name>. <article-title>The neutropenic diet: what&#x2019;s the evidence?</article-title>
<source>J Pediatr Hematol Oncol</source>. <year>2002</year>;<volume>24</volume>:<fpage>717</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1097/00043426-200212000-00007</pub-id><pub-id pub-id-type="pmid">12468911</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Floch</surname>
<given-names>MH</given-names></string-name>. <article-title>Recommendations for probiotic use in humans&#x2013;a 2014 update.</article-title>
<source>Pharmaceuticals (Basel)</source>. <year>2014</year>;<volume>7</volume>:<fpage>999</fpage>&#x2013;<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.3390/ph7100999</pub-id><pub-id pub-id-type="pmid">25310351</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
